Vida Ventures GP III, L.L.C.
SEC insider (Form 3/4/5 filer). CIK 0001855502. 10% Owner at Attovia Therapeutics, Inc. (ATTO) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on Sep 12, 2025. Located in LOS ANGELES, CA.
Companies Vida Ventures GP III, L.L.C. has filed insider reports for
- Attovia Therapeutics, Inc. (ATTO): 10% Owner
- LB PHARMACEUTICALS INC (LBRX): 10% Owner
Vida Ventures GP III, L.L.C.
CIK: 0001855502
Transaction Breakdown
Open Market Buys (P)2 (50.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)2 (50.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Sep 12, 2025LBRX
LB PHARMACEUTICALS INC
ConversionIndirect547.6K shares- - Sep 12, 2025LBRX
LB PHARMACEUTICALS INC
ConversionIndirect1.3K shares- - Sep 12, 2025LBRX
LB PHARMACEUTICALS INC
PurchaseIndirect332.6K shares at avg. $15.00$5.0M - Sep 12, 2025LBRX
LB PHARMACEUTICALS INC
PurchaseIndirect767 shares at avg. $15.00$12K
1-4 of 4 transactions